Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2

• Asıl Yazarlar: Xiang Tong (Yazar), Shijie Zhang (Yazar), Dongguang Wang (Yazar), Li Zhang (Yazar), Jizheng Huang (Yazar), Tianli Zhang (Yazar), Hong Fan (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Pulmonary fibrosis (PF) is a chronic and progressive process of tissue repair. Azithromycin (AZM) may be beneficial for the treatment of PF because AZM has anti-inflammatory and immune regulatory roles and inhibits remodeling, but the mechanism is not entirely clear. In this study, we established a...